A new study suggests that some people taking the popular weight-loss drug Semaglutide may face an unexpected downside: loss ...

By Vijay Kumar Malesu A daily pill version of GLP-1 therapy shows strong 72-week weight loss and metabolic improvements, offering a practical alternative to injectables. Study: Orforglipron, an Oral ...

This multicenter, prospective observational study is published in Frontiers in Clinical Diabetes and Healthcare. “Pre-treatment assessment of eating behavior patterns may help predict who will benefit ...

People with psoriasis might receive unexpected benefits from cutting-edge weight loss drugs like Ozempic and Zepbound, German ...

The results of this landmark trial are particularly significant, as oral therapies for obesity could improve both access to ...

Real-world data showed high incidence of hair loss among GLP-1 receptor agonist users, but the phenomenon is probably an ...

The largest and most comprehensive meta-analysis to date on glucagon-like peptide-1 (GLP-1) receptor agonists reveals ...

The once-daily oral GLP-1 RA orforglipron produces clinically and statistically significant weight loss and cardiometabolic ...

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight ...

The findings of this study suggest that metabolic bariatric surgery was associated with more weight loss at lower ongoing costs compared with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in ...